India
India has emerged as one of the world's fastest-accelerating global economies, marked by a rapid modernization of its IP laws. Concurrently, it retains complex, autonomous statutory hurdles, such as the stringent Section 3(d) restrictions for pharmaceutical inventions and demanding localized exploitation reporting requirements (Form 27). LEE & MOCK IP’s India Desk leverages a granular comprehension of these procedural complexities alongside a powerful local network to deliver expedited, cost-efficient IP acquisition blueprints specifically optimized for pharmaceutical, biotech, IT, and software enterprises.
Indian Patent Office (IPO) filings and targeted strategies for specialized statutory requirements (e.g., Section 3(d) compliance); management and compliance of Form 27 local working statements; IP portfolio consulting for market entry.
